INTERNET POSTING OF INVESTIGATIONAL DRUG NEWS COULD BE CONSIDERED PROMOTIONAL, FDA INDICATES; RESPONSES TO FALSE INFO ALSO TO BE DISCUSSED AT OCT. MEETING
Executive Summary
FDA is considering how to judge whether Internet postings about investigational drugs are promotional in context, the agency said in a Sept. 16 Federal Register notice.